From the Food and Drug Administration.
Nightingale
S L
SL
D005260:Female; D005568:Forms and Records Control; D006133:Growth Substances / Q000627:therapeutic use*; D016298:Hematopoietic Cell Growth Factors; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007880:Legislation, Drug; D009817:Office Management; D011663:Pulmonary Surfactants / Q000627:therapeutic use*; D012107:Research Design; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy / Q000517:prevention & control; D014481:United States; D014486:United States Food and Drug Administration
D006133:Growth Substances; D016298:Hematopoietic Cell Growth Factors; D011663:Pulmonary Surfactants